We are live on ! Find out more
SBC icon

SBC Medical Group

45 hedge funds and large institutions have $103M invested in SBC Medical Group in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,099% more capital inflows, than outflows

Capital inflows: $47.3M | Capital outflows: $1.48M

2,400% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 1

114% more funds holding

Funds holding: 21 → 45 (+24)

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

37.12% more ownership

Funds ownership: 45.36% → 82.48% (+37%)

Holders
45
Holders Change
+24
Holders Change %
+114.29%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
5
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SBC Hedge Fund Activity: Q4 2022 in Review

45 of the 6,243 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q4 2022, worth a combined $103M — up 85% from $55.4M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SBC positions and 1 closed out — a net gain of 24 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $4.3M. The largest seller was Parallax Volatility Advisers, exiting entirely with an estimated $1.2M sold.

  • 45 institutional investors held SBC Medical Group (SBC) as of Q4 2022, up from 21 in Q3 2022.
  • Funds reported $103M of SBC Medical Group stock for Q4 2022, up 85% quarter-over-quarter.
  • 25 funds opened new SBC Medical Group positions in Q4 2022 and 1 closed out, a net change of +24 holders.
  • The largest SBC Medical Group buyer in Q4 2022 was Bank of Montreal, an estimated $4.3M added.
  • The largest SBC Medical Group seller in Q4 2022 was Parallax Volatility Advisers, an estimated $1.2M sold.

Based on aggregated 13F filings for Q4 2022.